- Home
- MEGL vs ISPC Comparison
MEGL vs ISPC Comparison
Compare MEGL & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MEGL | ISPC |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5M | 5.7M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MEGL | ISPC |
|---|---|---|
| Price | $1.25 | $0.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.5K | ★ 1.8M |
| Earning Date | 10-17-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,296,394.00 | ★ $3,352,744.00 |
| Revenue This Year | N/A | $35.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.02 | $0.26 |
| 52 Week High | $3.06 | $3.18 |
Technical Indicators
Market Signals| Indicator | MEGL | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 47.30 |
| Support Level | $1.18 | $0.32 |
| Resistance Level | $1.35 | $0.37 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 29.63 | 39.20 |
Price Performance
Historical ComparisonAbout MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.